Complications of percutaneous treatment of thrombosed hemodialysis access grafts

Semin Dial. 2003 May-Jun;16(3):257-62. doi: 10.1046/j.1525-139x.2003.16049.x.

Abstract

Percutaneous catheter-based thrombolysis is commonly used in association with angioplasty to treat thrombosed hemodialysis arteriovenous grafts. Although major complications of these percutaneous procedures are relatively uncommon, they can result in several potentially serious complications, including pulmonary embolism, cerebral embolism, arterial embolism, bleeding with perigraft hematoma or hemorrhage, and vein rupture. This article reviews the epidemiology, clinical significance, and management of these complications.

Publication types

  • Review

MeSH terms

  • Arteriovenous Shunt, Surgical / adverse effects*
  • Embolism / etiology
  • Extravasation of Diagnostic and Therapeutic Materials / etiology
  • Graft Occlusion, Vascular / therapy*
  • Hemorrhage / etiology
  • Humans
  • Intracranial Embolism / etiology
  • Thrombolytic Therapy / adverse effects*
  • Thrombolytic Therapy / methods